Method of analysis of a Biological sample from a subject with Cancer Biomarkers using TNF, ripk1, cxl10, CCL5, nfkbia, herc5, CDYL, stk39 and mapk14 for inhibitory Therapy with IAP.

摘要

A method of selecting a subject having cancer for treatment with an IAP inhibitor.